NDC 87519-003 – Lyvispah

Baclofen 10 mg/1 · Granule · Oral

Human Prescription Drug

Product NDC87519-003

Product details

Brand name
Lyvispah
Generic name
baclofen
Labeler
Anvi Pharmaceuticals Inc
Dosage form
Granule
Route
Oral
Marketing category
NDA · NDA215422
Marketed since
September 1, 2026
Listing expires
December 31, 2027
Pharmacologic class
gamma-Aminobutyric Acid-ergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Lyvispah →

Package NDC codes (1)

Package NDCDescriptionSince
87519-003-9090 PACKET in 1 CARTON (87519-003-90) / 1 GRANULE in 1 PACKETSep 1, 2026

Other Lyvispah products